scispace - formally typeset
H

Henry G. Burger

Researcher at Prince Henry's Institute of Medical Research

Publications -  345
Citations -  22459

Henry G. Burger is an academic researcher from Prince Henry's Institute of Medical Research. The author has contributed to research in topics: Menopause & Follicle-stimulating hormone. The author has an hindex of 78, co-authored 345 publications receiving 21590 citations. Previous affiliations of Henry G. Burger include Walter and Eliza Hall Institute of Medical Research & Royal Children's Hospital.

Papers
More filters
Journal ArticleDOI

Inhibin and ovarian cancer.

TL;DR: In this article, the levels of immunoreactive inhibin (ir-inh) are elevated in almost all patients with granulosa cell tumours and in the majority of postmenopausal women with mucinous ovarian cancers.
Journal ArticleDOI

The rationale for physiological testosterone replacement in women

TL;DR: In this chapter, the changes in androgens as women age are reviewed, and the rationale for physiological androgen, specifically testosterone replacement, in women is addressed.
Journal ArticleDOI

Reproductive hormones: ageing and the perimenopause

TL;DR: The pituitary‐ovarian hormones involved with ageing and the onset of menopause, including inhibin B, and luteinizing hormone, show changes with age but these changes are poorly understood.
Journal ArticleDOI

Effects of a combination of Hypericum perforatum and Vitex agnus-castus on PMS-like symptoms in late-perimenopausal women: findings from a subpopulation analysis

TL;DR: Evaluated phytotherapeutic intervention comprising a combination of Hypericum perforatum (St. John's wort) and Vitex agnus-castus (chaste tree/berry) in the management of PMS-like symptoms in perimenopausal women suggested a potentially significant clinical application.
Journal ArticleDOI

Endocrine Features of Menstrual Cycles in Middle and Late Reproductive Age and the Menopausal Transition Classified According to the Staging of Reproductive Aging Workshop (STRAW) Staging System

TL;DR: Findings, although not conclusive, suggest that both inhibin B and anti-Mullerian hormone may be preferable to FSH for predicting STRAW stage with respect to the onset and progression of the menopausal transition.